Phibro Animal Health Expands Revolving Credit Facility Commitment

The latest update is out from Phibro Animal Health ( (PAHC) ).

On April 28, 2026, Phibro Animal Health Corporation amended its existing credit agreement with Coöperatieve Rabobank U.A., New York Branch and a syndicate of lenders, increasing its revolving credit commitment by $125 million, from $310 million to $435 million. The larger facility enhances the company’s financial flexibility and liquidity, potentially supporting operational needs, capital investments and strategic initiatives, while the detailed contractual terms and representations remain subject to negotiated qualifications and limitations among the parties.

The most recent analyst rating on (PAHC) stock is a Hold with a $62.00 price target. To see the full list of analyst forecasts on Phibro Animal Health stock, see the PAHC Stock Forecast page.

Spark’s Take on PAHC Stock

According to Spark, TipRanks’ AI Analyst, PAHC is a Neutral.

The score is driven primarily by improving financial performance (strong TTM margin and free-cash-flow recovery, but still-high leverage) and a notably positive earnings outlook after raised FY2026 guidance. Valuation is reasonable, while technical signals are mixed/neutral and corporate events introduce a modest regulatory overhang.

To see Spark’s full report on PAHC stock, click here.

More about Phibro Animal Health

Phibro Animal Health Corporation operates in the animal health and nutrition industry, providing products and services aimed at maintaining and improving the health, productivity and efficiency of livestock and other animals. The company’s business is closely tied to global agricultural and protein production markets, where access to flexible credit facilities can support working capital and growth initiatives.

Average Trading Volume: 300,359

Technical Sentiment Signal: Buy

Current Market Cap: $2.13B

For a thorough assessment of PAHC stock, go to TipRanks’ Stock Analysis page.